Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,609 GBX | -8.90% | -7.51% | +10.97% |
01:30pm | GSK to Face Trials Over Zantac Cancer Allegations; Shares Tumble Pre-Bell | MT |
01:26pm | GSK : Sell rating from JP Morgan | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.97% | 91.66B | |
+40.73% | 739B | |
+30.98% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.77% | 240B | |
+9.34% | 210B | |
-5.19% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GSK, Scynexis Sign License Deal for Fungal Infection Treatment